Lupus Research Alliance

Lupus Awareness Month

Hope in action: the future of Lupus

Get Involved
About Our Research Our bold plan to accelerate treatment and cure lupus What Is Lupus? Learn why it’s so complex For Researchers Discover resources and funding opportunities Donate Contribute to tomorrow’s treatments and cures.

Our Science Needs Your Story

Breakthroughs in research are unlocking the potential to turn the very complexity of lupus—its heterogeneity—into a cure. It’s an exciting new frontier. It’s a revolutionary approach.

Our success needs you—in the center of all we do. Hear from three active lupus advocates as they share why HOPE is the first word they associate with the LRA—the hope of community, results, and the power of being heard. And Albert Roy, President and CEO, describes how LRA is mobilizing the community to free the world of lupus by turning its very complexity to its cure.

Dedicated to Lupus Research

Our funding and work with the community have led to discoveries that are improving diagnosis and therapies while enabling researchers to turn complexity to cure. Yesterday, combatting lupus was a mystery. Today, thanks to the generosity of many, we have a clear strategy to move forward that builds upon a strong foundation of success.

But your help is critical for us to go further – to ensure we accelerate drug discovery and ultimately find a cure.

$284+ million to research
grants 100% of funds go to research
programs* 675+ Grants awarded to foster more
breakthroughs
*100% of your donation goes to support lupus research programs because the Lupus Research Alliance Board of Directors funds all administrative and fundraising expenses.

Latest Updates

Saphnelo™ Approved as Self-Administered Autoinjector

The U.S. Food and Drug Administration just granted approval for a self-administered, once-weekly autoinjector of Saphenlo (anifrolumab), for the treatment of adult patients with systemic lupus erythematosus (SLE) on...

Press Stories & News
Join us
Get involved in research, donate, walk, and advocate
Michael Niggel April 21, 2017